Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial

DiscussionThe present randomized, controlled clinical trial would indicate the additive effects of the combination of OK lens and 0.01% atropine, and the extent of these effects, in retarding myopia progression and axial elongation in children.Trial registrationChinese Clinical Trial Registry (ChiCTR),ChiCTR1800018419. Registered on 17 September 2018.http://www.chictr.org.cn/showproj.aspx?proj=29216
Source: Trials - Category: Research Source Type: clinical trials